Participated · Equity · Jun 2026

ALT Sports Data offers a technology and services platform — described as a League Operating System — that bundles official data rights, integrity and compliance services, fan engagement and media tools, and commercial distribution across gaming and streaming. The platform is modular so leagues can adopt capabilities incrementally and scale into additional products over time. ASD works with more than 30 sports properties worldwide, including Formula 1, World Surf League, X Games, SuperMotocross World Championships, Bare Knuckle Fighting Championship, and Professional Bull Riders. The company has experienced significant growth over the past eighteen months and recently became Formula 1’s Official Betting Data Supplier. With the newly raised $5 million, ASD intends to invest further in product development, AI, league onboarding, integrity and compliance, sports betting and fan engagement offerings, and international expansion. The company continues to expand its global operator network and strategic services to create new commercial opportunities for leagues while maintaining control of audience and intellectual property.

Participated · Equity · Mar 2026

Sequential operates a proprietary non-invasive testing platform that integrates microbial and molecular analyses to quantify how ingredients and consumer, biotech, and pharmaceutical products alter skin biomarkers. The company has amassed one of the industry’s largest clinical datasets with over 50,000 samples, 4,000+ ingredients tested, and 10,000+ participants worldwide. Sequential runs labs in Cambridge, New York City and Singapore and has received support from Innovate UK, Enterprise Singapore and A*STAR among others. Following its $3.5M first equity round, bringing total dilutive and non-dilutive funding to $7.5M, the company plans to build an AI-driven discovery engine to predict, optimize and discover next‑generation active complexes and bioactive ingredients. Sequential is also expanding its biomarker discovery programs and global partnerships to commercialize scientifically validated ingredient complexes.

Participated · Series A · Jan 2026

Tradespace has built an AI-native IP Management Platform that embeds directly into R&D workflows so corporations can harvest inventions, search prior art, draft applications, respond to office actions, and launch licensing campaigns without relying on outside counsel. The system replaces the billable hour with automated, attorney-grade drafting tools, enabling companies to file patents in under 24 hours while preserving legal rigor. Customers report a 50% cut in outside counsel spend, a 40% rise in invention disclosures, and a dramatic compression of time-to-file from weeks to days. Today the platform manages more than 440,000 patents for over 80 organizations, including Fortune 500 tech giants and three-quarters of the top U.S. research universities. In November 2025 Tradespace acquired Paragon Patents, strengthening its agentic AI workflows and solidifying its technical lead in automated patent drafting. Fresh capital from its Series A round will be used to scale the product and further integrate AI across the IP lifecycle.

Participated · Seed · Oct 2025

Eztia Materials develops and manufactures HydraVolt™, a tunable polymer-gel that can be embedded into clothing and gear to absorb body heat and cut skin temperature by roughly 10 °C for as long as eight hours of strenuous activity. The material recharges with ordinary water, making it practical for use in construction, defense, public safety, and other heat-exposed industries. Current customers and pilot partners include PSA Singapore, Singapore’s Ministry of Home Affairs, Japan’s Kajima Construction, California-based Muller Construction Supply, and units of the U.S. military. The company cites a global market need driven by rising heat stress, which causes nearly 500,000 deaths annually and an estimated $100 billion in U.S. productivity losses. Proceeds from its recent financing will help scale manufacturing capacity and accelerate international expansion, especially across Asia. Headquartered in San Francisco, Eztia is led by CEO and co-founder Tiffany Yeh and supported by physicians and materials engineers. While revenue figures were not disclosed, the firm is focusing resources on commercializing HydraVolt and broadening its customer base in construction, logistics, and defense.

Participated · Equity · Mar 2025

Olio Labs operates an AI-powered therapeutic design platform centered on a combination design engine (CoDE) that integrates human medical records and biological data, in‑vivo phenomic screening, and neural and endocrine circuit maps. The platform fuses computational methods with biological expertise to shift pharmaceutical research from a molecule-first to a patient-first approach. Olio Labs highlights AI-powered integration of biological expertise as a core capability of CoDE. Led by CEO David Tingley, the company plans to use the new capital to expand operations and advance its development efforts. Its advisory board includes industry veterans Patricia Martin, Michael Schwartz, and Hugh Reinhoff. The company announced the funding in March 2025. Olio Labs uses artificial intelligence and machine learning to design combination therapeutics that account for complex interactions among thousands of proteins. Their AI-driven compute-experiment platform can design and test trillions of combinations, which the company says has accelerated discovery fourfold and reduced costs by 90%. Olio Labs is focused on discovering combinations that can outperform best-in-class obesity drugs and has reported promising results in animal models, including significant appetite reduction with associated decreases in nausea. The platform targets both combinations of existing drugs and novel targets. The company was founded by Dr. David Tingley and Dr. Tom Roseberry, whose backgrounds include Harvard, New York University, and Neuralink, and the team is expanding to accelerate research. Olio Labs participated in Y Combinator’s S23 batch and recently attracted investment from ZAKA VC.